DE602006009899D1 - Verwendung von oxycodon zur behandlung von viszeralem schmerz - Google Patents

Verwendung von oxycodon zur behandlung von viszeralem schmerz

Info

Publication number: DE602006009899D1
Authority: DE; Germany
Prior art keywords: oxycodone; treatment; visceral pain; visceral; pain
Prior art date: 2005-01-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE602006009899T

Other languages

English (en)

Inventor

Asbjorn Mohr Drewes

Lars Arendt Nielsen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Euro Celtique SA

Original Assignee

Euro Celtique SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-18

Filing date

2006-01-17

Publication date

2009-12-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35871217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006009899(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-01-17 Application filed by Euro Celtique SA filed Critical Euro Celtique SA

2009-12-03 Publication of DE602006009899D1 publication Critical patent/DE602006009899D1/de

2026-01-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)

DE602006009899T 2005-01-18 2006-01-17 Verwendung von oxycodon zur behandlung von viszeralem schmerz Expired - Lifetime DE602006009899D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US64549005P	2005-01-18	2005-01-18
PCT/EP2006/050252 WO2006077212A1 (en)	2005-01-18	2006-01-17	Use of oxycodone for treating visceral pain

Publications (1)

Publication Number	Publication Date
DE602006009899D1 true DE602006009899D1 (de)	2009-12-03

Family

ID=35871217

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE202006019887U Expired - Lifetime DE202006019887U1 (de)	2005-01-18	2006-01-17	Medikament zur Behandlung von viszeralem Schmerz
DE602006009899T Expired - Lifetime DE602006009899D1 (de)	2005-01-18	2006-01-17	Verwendung von oxycodon zur behandlung von viszeralem schmerz

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE202006019887U Expired - Lifetime DE202006019887U1 (de)	2005-01-18	2006-01-17	Medikament zur Behandlung von viszeralem Schmerz

Country Status (31)

Country	Link
US (2)	US20080200493A1 (de)
EP (1)	EP1838318B1 (de)
JP (1)	JP5049139B2 (de)
KR (10)	KR20230170811A (de)
CN (1)	CN101106996B (de)
AP (1)	AP2249A (de)
AR (1)	AR052880A1 (de)
AT (2)	ATE446092T1 (de)
AU (1)	AU2006207498B2 (de)
BR (1)	BRPI0606247A2 (de)
CA (1)	CA2595043C (de)
CY (1)	CY1109660T1 (de)
DE (2)	DE202006019887U1 (de)
DK (2)	DK1838318T3 (de)
EA (1)	EA013544B1 (de)
ES (1)	ES2333901T3 (de)
HR (1)	HRP20090679T1 (de)
IL (1)	IL184530A (de)
ME (1)	ME01066B (de)
MX (1)	MX2007007207A (de)
MY (1)	MY144471A (de)
NO (1)	NO338968B1 (de)
NZ (1)	NZ555852A (de)
PL (1)	PL1838318T3 (de)
PT (1)	PT1838318E (de)
RS (1)	RS51069B (de)
SI (1)	SI1838318T1 (de)
TW (1)	TWI432196B (de)
UA (1)	UA85471C2 (de)
WO (1)	WO2006077212A1 (de)
ZA (1)	ZA200705231B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1957106B2 (de)	2005-11-14	2019-07-24	Teva Pharmaceuticals International GmbH	Antagonisten-antikörper gegen calcitonin-gen-related-peptid und verfahren damit
US8821928B2 (en)	2007-06-04	2014-09-02	Egalet Ltd.	Controlled release pharmaceutical compositions for prolonged effect
JP5537441B2 (ja)	2008-03-04	2014-07-02	ファイザー・リミテッド	慢性疼痛を治療する方法
WO2010089132A1 (en)	2009-02-06	2010-08-12	Egalet A/S	Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en)	2009-06-24	2010-12-29	Egalet Ltd.	Controlled release formulations
KR101519192B1 (ko)	2009-08-28	2015-05-11	리나트 뉴로사이언스 코프.	칼시토닌 유전자-관련된 펩티드에 대해 지시된 길항제 항체의 투여에 의한 내장 통증의 치료 방법
DK2709663T3 (da)	2011-05-20	2019-05-20	Alderbio Holdings Llc	Anvendelse af anti-CGRP-antistoffer og antistoffragmenter til forebyggelse eller inhibering af fotofobi eller aversion mod lys hos individer med behov herfor, især migrænikere
US9855332B2 (en)	2011-05-20	2018-01-02	Alderbio Holdings Llc	Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels
SG10201604040PA (en)	2011-05-20	2016-07-28	Alderbio Holdings Llc	Anti-cgrp compositions and use thereof
US20170114122A1 (en)	2015-10-23	2017-04-27	Alderbio Holdings Llc	Regulation of glucose metabolism using anti-cgrp antibodies
US10556945B2 (en)	2014-03-21	2020-02-11	Teva Pharmaceuticals International Gmbh	Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
SI3119431T1 (sl)	2014-03-21	2024-06-28	Teva Pharmaceuticals International Gmbh	Antagonistična protitelesa, usmerjena proti peptidu, povezanemu z genom za kalcitonin, in postopki za uporabo le-teh
PE20191148A1 (es)	2016-09-23	2019-09-02	Teva Pharmaceuticals Int Gmbh	Tratamiento de la migrana refractaria
BR112021006027A2 (pt)	2018-11-19	2021-06-29	Jazz Pharmaceuticals Ireland Limited	formulações de fármaco resistente a álcool
CR20210373A (es)	2019-01-08	2021-08-19	H Lundbeck As	Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp
AU2020202454A1 (en)	2020-04-06	2021-10-21	H. Lundbeck A/S	Treatment of most bothersome symptom (MBS) associated with migraine using anti-CGRP antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5656295A (en) *	1991-11-27	1997-08-12	Euro-Celtique, S.A.	Controlled release oxycodone compositions
US5958459A (en) *	1991-12-24	1999-09-28	Purdue Pharma L.P.	Opioid formulations having extended controlled released
US5968551A (en) *	1991-12-24	1999-10-19	Purdue Pharma L.P.	Orally administrable opioid formulations having extended duration of effect
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
IL110014A (en) *	1993-07-01	1999-11-30	Euro Celtique Sa	Solid controlled-release oral dosage forms of opioid analgesics
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
PL187926B1 (pl) *	1996-03-25	2004-11-30	Lilly Co Eli	Kompozycja farmaceutyczna do leczenia bólu
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
US6992193B2 (en) *	2003-06-10	2006-01-31	Adolor Corporation	Sulfonylamino phenylacetamide derivatives and methods of their use

2006
- 2006-01-05 TW TW095100458A patent/TWI432196B/zh not_active IP Right Cessation
- 2006-01-09 MY MYPI20060082A patent/MY144471A/en unknown
- 2006-01-17 JP JP2007550797A patent/JP5049139B2/ja not_active Expired - Fee Related
- 2006-01-17 KR KR1020237042001A patent/KR20230170811A/ko not_active Ceased
- 2006-01-17 DE DE202006019887U patent/DE202006019887U1/de not_active Expired - Lifetime
- 2006-01-17 UA UAA200708142A patent/UA85471C2/ru unknown
- 2006-01-17 KR KR1020177004572A patent/KR20170021905A/ko not_active Ceased
- 2006-01-17 NZ NZ555852A patent/NZ555852A/en unknown
- 2006-01-17 EA EA200701541A patent/EA013544B1/ru not_active IP Right Cessation
- 2006-01-17 HR HR20090679T patent/HRP20090679T1/hr unknown
- 2006-01-17 SI SI200630538T patent/SI1838318T1/sl unknown
- 2006-01-17 BR BRPI0606247-4A patent/BRPI0606247A2/pt not_active Application Discontinuation
- 2006-01-17 KR KR1020197035201A patent/KR20190135557A/ko not_active Ceased
- 2006-01-17 DK DK06700652T patent/DK1838318T3/da active
- 2006-01-17 EP EP06700652A patent/EP1838318B1/de not_active Expired - Lifetime
- 2006-01-17 CN CN2006800024739A patent/CN101106996B/zh not_active Expired - Lifetime
- 2006-01-17 ES ES06700652T patent/ES2333901T3/es not_active Expired - Lifetime
- 2006-01-17 DE DE602006009899T patent/DE602006009899D1/de not_active Expired - Lifetime
- 2006-01-17 KR KR1020127011713A patent/KR20120089710A/ko not_active Ceased
- 2006-01-17 RS RSP-2009/0553A patent/RS51069B/sr unknown
- 2006-01-17 KR KR1020077018905A patent/KR20070100368A/ko not_active Ceased
- 2006-01-17 MX MX2007007207A patent/MX2007007207A/es active IP Right Grant
- 2006-01-17 KR KR1020207031796A patent/KR20200128451A/ko not_active Ceased
- 2006-01-17 PL PL06700652T patent/PL1838318T3/pl unknown
- 2006-01-17 AP AP2007004057A patent/AP2249A/xx active
- 2006-01-17 AT AT06700652T patent/ATE446092T1/de active
- 2006-01-17 KR KR1020147018838A patent/KR20140091782A/ko not_active Ceased
- 2006-01-17 AU AU2006207498A patent/AU2006207498B2/en not_active Expired
- 2006-01-17 KR KR1020087029312A patent/KR20080106991A/ko not_active Ceased
- 2006-01-17 KR KR1020217034339A patent/KR20210131450A/ko not_active Ceased
- 2006-01-17 WO PCT/EP2006/050252 patent/WO2006077212A1/en not_active Ceased
- 2006-01-17 KR KR1020227041445A patent/KR20220165797A/ko not_active Ceased
- 2006-01-17 ME MEP-2009-352A patent/ME01066B/me unknown
- 2006-01-17 US US11/814,020 patent/US20080200493A1/en not_active Abandoned
- 2006-01-17 CA CA2595043A patent/CA2595043C/en not_active Expired - Lifetime
- 2006-01-17 PT PT06700652T patent/PT1838318E/pt unknown
- 2006-01-18 AR ARP060100177A patent/AR052880A1/es unknown
2007
- 2007-03-09 AT AT0014807U patent/AT9895U1/de not_active IP Right Cessation
- 2007-07-02 ZA ZA200705231A patent/ZA200705231B/xx unknown
- 2007-07-10 IL IL184530A patent/IL184530A/en active IP Right Grant
- 2007-07-24 DK DK200700207U patent/DK200700207U3/da not_active IP Right Cessation
- 2007-08-14 NO NO20074174A patent/NO338968B1/no not_active IP Right Cessation
2009
- 2009-12-16 CY CY20091101308T patent/CY1109660T1/el unknown
2014
- 2014-10-15 US US14/515,216 patent/US9271974B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NZ555852A (en)	2010-01-29
ES2333901T3 (es)	2010-03-02
AU2006207498B2 (en)	2009-11-19
UA85471C2 (ru)	2009-01-26
KR20210131450A (ko)	2021-11-02
NO20074174L (no)	2007-10-17
CA2595043A1 (en)	2006-07-27
US9271974B2 (en)	2016-03-01
AT9895U1 (de)	2008-05-15
TWI432196B (zh)	2014-04-01
AR052880A1 (es)	2007-04-11
KR20120089710A (ko)	2012-08-13
KR20140091782A (ko)	2014-07-22
PL1838318T3 (pl)	2010-03-31
SI1838318T1 (sl)	2010-02-26
KR20200128451A (ko)	2020-11-12
PT1838318E (pt)	2009-12-15
DK200700207U3 (da)	2007-09-28
JP2008526927A (ja)	2008-07-24
RS51069B (sr)	2010-10-31
HRP20090679T1 (hr)	2010-01-31
ME01066B (me)	2012-10-20
HK1107933A1 (en)	2008-04-25
MY144471A (en)	2011-09-30
KR20220165797A (ko)	2022-12-15
CN101106996B (zh)	2013-10-23
KR20080106991A (ko)	2008-12-09
BRPI0606247A2 (pt)	2009-06-09
NO338968B1 (no)	2016-11-07
ZA200705231B (en)	2008-06-25
EP1838318A1 (de)	2007-10-03
US20150190393A1 (en)	2015-07-09
AP2007004057A0 (en)	2007-08-31
WO2006077212A1 (en)	2006-07-27
DK200700207U1 (da)	2007-08-24
IL184530A (en)	2015-01-29
CY1109660T1 (el)	2014-08-13
CN101106996A (zh)	2008-01-16
CA2595043C (en)	2013-11-19
KR20190135557A (ko)	2019-12-06
IL184530A0 (en)	2007-10-31
ATE446092T1 (de)	2009-11-15
DE202006019887U1 (de)	2007-07-26
AU2006207498A1 (en)	2006-07-27
US20080200493A1 (en)	2008-08-21
JP5049139B2 (ja)	2012-10-17
EA200701541A1 (ru)	2008-02-28
KR20170021905A (ko)	2017-02-28
MX2007007207A (es)	2007-08-15
KR20070100368A (ko)	2007-10-10
EP1838318B1 (de)	2009-10-21
DK1838318T3 (da)	2010-01-04
EA013544B1 (ru)	2010-06-30
AP2249A (en)	2011-07-18
TW200637554A (en)	2006-11-01
KR20230170811A (ko)	2023-12-19

Publication	Publication Date	Title
ATE399155T1 (de)	2008-07-15	Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
ATE512663T1 (de)	2011-07-15	Kombination zur behandlung von erkrankungen mit zellproliferation
EP1755661A4 (de)	2008-02-20	Verwendung von gelsolin zur behandlung von infektionen
ATE527241T1 (de)	2011-10-15	Pyridiazinonderivate zur behandlung von tumoren
DE602006019560D1 (de)	2011-02-24	2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
ATE434620T1 (de)	2009-07-15	Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
ATE440866T1 (de)	2009-09-15	Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
IL184530A0 (en)	2007-10-31	Use of oxycodone for treating visceral pain
ATE429218T1 (de)	2009-05-15	Pinolensäure zur behandlung von übergewicht
DE60313021D1 (de)	2007-05-16	4-tetrazolyl-4-phenylpiperidindervate zur schmerzbehandlung
ATE447551T1 (de)	2009-11-15	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE443704T1 (de)	2009-10-15	Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602005021970D1 (de)	2010-08-05	Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
DE502005010499D1 (de)	2010-12-23	Implantat zur Behandlung von Fettsucht
DE602004019576D1 (de)	2009-04-02	Zur behandlung von schmerzen geeignete piperazine
ATE504297T1 (de)	2011-04-15	Visnadin zur behandlung von kopfhautjucken
DE602006017367D1 (de)	2010-11-18	Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602005016141D1 (de)	2009-10-01	S-mirtazapin zur behandlung von hitzewallungen
DE602005027251D1 (de)	2011-05-12	Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
ATE482707T1 (de)	2010-10-15	1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
EP2403501A4 (de)	2012-09-19	Pregnenolonsulfat zur behandlung von neurologischen erkrankungen
DE602005013287D1 (de)	2009-04-23	Zusammensetzung zur behandlung von leder
DE602005015442D1 (de)	2009-08-27	Kollagen-polyvinylpyrrolidon zur behandlung von osteoarthritis
DE502005002104D1 (de)	2008-01-10	Hesperidin zur Behandlung von Epilepsie
DE602004003252D1 (de)	2006-12-28	Verwendung von 2h-ä1,3ü-oxazinoä3,2-aüindol-derivaten zur behandlung von neuropathischem schmerz

Legal Events

Date	Code	Title	Description
2010-10-07	8363	Opposition against the patent